Peer review reports
From: Prognostic marker CXCL5 in glioblastoma polyformis and its mechanism of immune invasion
Original Submission | ||
---|---|---|
19 Apr 2023 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
Resubmission - Version 3 | ||
Submitted | Manuscript version 3 | |
Resubmission - Version 4 | ||
Submitted | Manuscript version 4 | |
19 Aug 2023 | Reviewed | Reviewer Report |
19 Aug 2023 | Reviewed | Reviewer Report |
23 Aug 2023 | Reviewed | Reviewer Report - Yuting Liu |
20 Sep 2023 | Author responded | Author comments - Chen Rui |
Resubmission - Version 5 | ||
20 Sep 2023 | Submitted | Manuscript version 5 |
8 Oct 2023 | Author responded | Author comments - Chen Rui |
Resubmission - Version 6 | ||
8 Oct 2023 | Submitted | Manuscript version 6 |
9 Oct 2023 | Author responded | Author comments - Chen Rui |
Resubmission - Version 7 | ||
9 Oct 2023 | Submitted | Manuscript version 7 |
10 Oct 2023 | Author responded | Author comments - Chen Rui |
Resubmission - Version 8 | ||
10 Oct 2023 | Submitted | Manuscript version 8 |
10 Oct 2023 | Author responded | Author comments - Chen Rui |
Resubmission - Version 9 | ||
10 Oct 2023 | Submitted | Manuscript version 9 |
11 Oct 2023 | Author responded | Author comments - Chen Rui |
Resubmission - Version 10 | ||
11 Oct 2023 | Submitted | Manuscript version 10 |
7 Nov 2023 | Reviewed | Reviewer Report |
12 Nov 2023 | Reviewed | Reviewer Report |
Resubmission - Version 11 | ||
Submitted | Manuscript version 11 | |
Publishing | ||
17 Nov 2023 | Editorially accepted | |
29 Jan 2024 | Article published | 10.1186/s12885-023-11650-3 |